Araclon Biotech S.L. clinical trials
Acquired by Grifols, Mar 2012 · source ↗
The registry lists 2 studies whose lead sponsor is Araclon Biotech S.L.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated May 5, 2026.
Before and after it joined Grifols
- First submitted before Araclon Biotech S.L. became part of Grifols
- 0
- First submitted after Araclon Biotech S.L. became part of Grifols
- 2
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Araclon Biotech S.L.2 studies
Something wrong with this grouping? Tell us on the Grifols page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Grifols studies →
- Safety and Immunogenicity of Repeated Doses of ABvac40 in Patients With a-MCI or Vm-ADCompletedNCT03461276Phase 2
Sponsor listed in the registry: Araclon Biotech S.L. · First submitted after Araclon Biotech S.L. became part of Grifols
- Repeated Subcutaneous Administration of ABvac40 in Mild to Moderate Alzheimer's Disease PatientsCompletedNCT03113812Phase 1
Sponsor listed in the registry: Araclon Biotech S.L. · First submitted after Araclon Biotech S.L. became part of Grifols